ABDI IBRAHIM Turkey (ABDI İBRAHİM İlaç Sanayi ve Ticaret A.Ş.) is a Turkish pharmaceutical company that was founded in 1912. It is one of the leading pharmaceutical companies in Turkey and has an important position in the global market.
The company specializes in the production and sale of a wide range of pharmaceuticals including prescription drugs, over-the-counter drugs and vaccines. It is active in areas such as cardiology, oncology, gynecology, gastroenterology, neurology, antibiotics, antiviral drugs, and many more. The company also manufactures medical devices and medical equipment.
ABDI IBRAHIM Turkey prioritizes the quality of its products and strictly follows international quality and safety standards. The company invests significant resources in research and development to develop new innovative products and improve existing products. As a result, ABDI IBRAHIM Turkey has a strong market position and contributes to the health care of patients.
The company is also active in exporting its products and has offices and partners in various countries. Its products are exported to many countries in Africa, Asia, Europe and other regions, enabling it to make an impact on a global level and promote the spread of modern medical technologies.
ABDI IBRAHIM Turkey adheres to high standards of corporate social responsibility and sustainable development, focusing its efforts on environmental protection, supporting social programs and participating in charitable and cultural activities.
Since its establishment, ABDI IBRAHIM Turkey has come a long way in its development and has become a respected player in the global pharmaceutical industry. Its commitment to innovation, product quality and responsible attitude make it a prominent player in ensuring the health and well-being of patients.